- Home
- AVIR vs OTLY Comparison
AVIR vs OTLY Comparison
Compare AVIR & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | OTLY |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 337.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVIR | OTLY |
|---|---|---|
| Price | $4.74 | $12.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $6.00 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 580.2K | 74.1K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | $6.52 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $6.45 |
| 52 Week High | $4.70 | $18.84 |
Technical Indicators
Market Signals| Indicator | AVIR | OTLY |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 55.02 |
| Support Level | $4.04 | $10.94 |
| Resistance Level | $4.50 | $12.75 |
| Average True Range (ATR) | 0.24 | 0.86 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 93.23 | 78.86 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.